While the pathophysiological role of ERBB3 and ERBB4 in CCA is still unknown, several studies have described the tumorigenic role of EGFR and ERBB2 in CCA, which is mediated by the activation of MAPK-ERK or PI3k-mTOR pathways [59]. This evidence concerns the gene ERBB3 and cholangiocarcinoma.